HealthQuill Articles by: HealthQuill
A four-year-old child in India has been detected with avian influenza A(H9N2) in the Eastern state of West Bengal, the World Health Organization reported.
Drugs Health Pharma

Child in India detected with bird flu in eastern West Bengal state: WHO 

A four-year-old child in India has been detected with avian influenza A(H9N2) in the Eastern state of West Bengal, the World Health Organization

Read More
A 59-year-old person in Mexico died in April after contracting avian influenza A(H5N2) virus, the first such death in the country, according to the World Health Organization.
Drugs Health Pharma

Person in Mexico dies after contracting avian influenza, WHO says

A 59-year-old person in Mexico died in April after contracting avian influenza A(H5N2) virus, the first such death in the country, according to

Read More
The advisory committee of the US Food and Drug Administration has rejected a therapy using party drug MDMA, or ecstasy or molly to treat post-traumatic stress disorder.
Drugs Health Pharma

FDA advisers reject psychedelic party drug MDMA to treat PSTD in adults

The advisory committee of the US Food and Drug Administration has rejected a therapy using party drug MDMA, or ecstasy or molly to

Read More
AstraZeneca announced the completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, for $2.4 billion.
Drugs Health Pharma

AstraZeneca completes $2.4 billion acquisition of Fusion Pharma

AstraZeneca announced the completion of the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, for $2.4 billion.

Read More
Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or melanoma.
Drugs Health Pharma

Moderna, Merck’s skin cancer vaccine shows rise in survival rates

Moderna’s mRNA vaccine candidate in combination with Merck Co.’s, therapy, Keytruda, showed greater survival rates and efficacy in patients with skin cancer or

Read More
Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer responds to immunotherapy drugs.
Drugs Health Pharma

NIH researchers make AI tool to read cancer responses to immunotherapy

Researchers at the National Institutes of Health have developed an artificial intelligence tool that uses a simple blood test to predict if cancer

Read More
British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a standard-of-care combination, according to the company.
Drugs Health Pharma

GSK’s blood cancer test drug halves risk of disease progression: Data 

British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a

Read More
AstraZeneca, Daiichi’s breast cancer drug trial results show improvement in progression-free survival
Drugs Health Pharma

AstraZeneca, Daiichi’s breast cancer drug trials show rise in survival

HQ Team June 3, 2024: An antibody-drug conjugate, jointly being developed by AstraZeneca and Daiichi Sankyo, has been shown in end-stage clinical trials

Read More
Negotiations at reaching a global accord to help fight pandemics better will conclude by 2025 or “earlier if possible at a special session of the World Health Assembly in 2024,” according to the World Health Organization.
Drugs Health Pharma

Global pandemic accord may see the light of day in 2025, ‘or earlier’: WHO

Negotiations at reaching a global accord to help fight pandemics better will conclude by 2025 or “earlier if possible at a special session

Read More
Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression after five years, according to company data.
Drugs Health Pharma

Pfizer’s drug helps people with rare lung cancer live longer, data shows

Sixty percent of the patients treated with Pfizer’s Lorbrena drug, for a rare form of advanced lung cancer, were alive without disease progression

Read More